These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 19530931)
1. Enhancement of nasal absorption of calcitonin loaded in liposomes. Law SL; Huang KJ; Chou VH; Cherng JY J Liposome Res; 2001; 11(2-3):165-74. PubMed ID: 19530931 [TBL] [Abstract][Full Text] [Related]
2. Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery. Chen M; Li XR; Zhou YX; Yang KW; Chen XW; Deng Q; Liu Y; Ren LJ Peptides; 2009 Jul; 30(7):1288-95. PubMed ID: 19540427 [TBL] [Abstract][Full Text] [Related]
3. Preparation of desmopressin-containing liposomes for intranasal delivery. Law SL; Huang KJ; Chou HY J Control Release; 2001 Feb; 70(3):375-82. PubMed ID: 11182207 [TBL] [Abstract][Full Text] [Related]
4. Characterization of calcitonin-containing liposome formulations for intranasal delivery. Law SL; Shih CL J Microencapsul; 2001; 18(2):211-21. PubMed ID: 11253938 [TBL] [Abstract][Full Text] [Related]
5. Preliminary investigation of the nasal delivery of liposomal leuprorelin acetate for contraception in rats. Shahiwala A; Misra A J Pharm Pharmacol; 2006 Jan; 58(1):19-26. PubMed ID: 16393460 [TBL] [Abstract][Full Text] [Related]
6. Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. Law SL; Huang KJ; Chiang CH J Control Release; 2000 Jan; 63(1-2):135-40. PubMed ID: 10640587 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of gelatin microspheres for nasal and intramuscular administrations of salmon calcitonin. Morimoto K; Katsumata H; Yabuta T; Iwanaga K; Kakemi M; Tabata Y; Ikada Y Eur J Pharm Sci; 2001 May; 13(2):179-85. PubMed ID: 11297902 [TBL] [Abstract][Full Text] [Related]
8. Emulsion formulations of testosterone for nasal administration. Ko KT; Needham TE; Zia H J Microencapsul; 1998; 15(2):197-205. PubMed ID: 9532525 [TBL] [Abstract][Full Text] [Related]
9. Effect of surface charge and density of distearylphosphatidylethanolamine-mPEG-2000 (DSPE-mPEG-2000) on the cytotoxicity of liposome-entrapped ricin: effect of lysosomotropic agents. Rathore SS; Ghosh PC Int J Pharm; 2008 Feb; 350(1-2):79-94. PubMed ID: 17913409 [TBL] [Abstract][Full Text] [Related]
10. Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation. Werle M; Takeuchi H Int J Pharm; 2009 Mar; 370(1-2):26-32. PubMed ID: 19073243 [TBL] [Abstract][Full Text] [Related]
11. The influence of the enhancer dimyristoylphosphatidylglycerol and formulation factors on the nasal absorption of salmon calcitonin. Dua R; Duncan M; Zia H; Needham TE Drug Deliv; 1998; 5(2):127-34. PubMed ID: 19570004 [TBL] [Abstract][Full Text] [Related]
12. Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes. Thirawong N; Thongborisute J; Takeuchi H; Sriamornsak P J Control Release; 2008 Feb; 125(3):236-45. PubMed ID: 18082282 [TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. Takeuchi H; Matsui Y; Yamamoto H; Kawashima Y J Control Release; 2003 Jan; 86(2-3):235-42. PubMed ID: 12526820 [TBL] [Abstract][Full Text] [Related]
14. Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits. Amin M; Jaafari MR; Tafaghodi M Colloids Surf B Biointerfaces; 2009 Nov; 74(1):225-9. PubMed ID: 19699067 [TBL] [Abstract][Full Text] [Related]
15. Increase of the pharmacological and pharmacokinetic efficacy of negatively charged polypeptide recombinant hirudin in rats via parenteral route by association with cationic liposomes. Meng M; Liu Y; Wang YB; Wang JC; Zhang H; Wang XQ; Zhang X; Lu WL; Zhang Q J Control Release; 2008 Jun; 128(2):113-9. PubMed ID: 18423766 [TBL] [Abstract][Full Text] [Related]
16. [Intranasal absorption of various calcitonin spray preparations]. Pisati P; Feletti F; De Bernardi M; Tripodi AS; Contos S; Germogli R; Molteni R; Covini D Boll Chim Farm; 1992 Mar; 131(3):120-7. PubMed ID: 1418891 [TBL] [Abstract][Full Text] [Related]
17. The influence of liposomal formulation factors on the interactions between liposomes and hydroxyapatite. Nguyen S; Solheim L; Bye R; Rykke M; Hiorth M; Smistad G Colloids Surf B Biointerfaces; 2010 Mar; 76(1):354-61. PubMed ID: 20022224 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Takeuchi H; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y Int J Pharm; 2005 Oct; 303(1-2):160-70. PubMed ID: 16125348 [TBL] [Abstract][Full Text] [Related]
19. Positively and negatively charged liposomes as carriers for transdermal delivery of sumatriptan: in vitro characterization. Villasmil-Sánchez S; Drhimeur W; Ospino SC; Rabasco Alvarez AM; González-Rodríguez ML Drug Dev Ind Pharm; 2010 Jun; 36(6):666-75. PubMed ID: 20136486 [TBL] [Abstract][Full Text] [Related]
20. [The hypocalcemia effect of salmon calcitonin ultra-flexible liposomes after intranasal administration in rats]. Chen M; Deng Q; Li XR; Liu Y Yao Xue Xue Bao; 2007 Jun; 42(6):681-6. PubMed ID: 17702409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]